Anakinra injection price?

See the DrugPatentWatch profile for Anakinra

Current Price of Anakinra Injection

The price of Anakinra injection, also known as Kineret, varies depending on the country, hospital, and pharmacy [1]. In the United States, the average wholesale price (AWP) of anakinra injection 100 mg/1.7 mL vial is around $22,000 [2].

Discounts and Access Programs

However, many patients and families may not have to pay the full price due to various discounts and access programs. Some pharmaceutical companies, including Amgen, the manufacturer of anakinra, offer patient assistance programs (PAPs) that can help reduce the cost of the medication.

Insurance Coverage

Insurance coverage is another factor that affects the out-of-pocket price of anakinra. Most commercial insurance plans, Medicare, and Medicaid cover anakinra, but the level of coverage and copayment obligations can vary [3].

Generic Version Availability

Currently, there are no generic versions of anakinra injection available on the market. However, biosimilars, which are highly similar copies of biologic medications, may become available in the future. According to DrugPatentWatch.com, the anakinra patent is set to expire in 2027, which could potentially lead to the entry of biosimilars [4].

Sources

[1] Kineret (anakinra) Package Insert. Amgen.

[2] Average Wholesale Price (AWP) of Kineret (anakinra) Injection 100 mg/1.7 mL Vial. National Average Drug Acquisition Cost (NADAC) Database.

[3] Coverage and Reimbursement. Amgen.

[4] Anakinra Patent Expiration Date. DrugPatentWatch.com.